Related references
Note: Only part of the references are listed.Effectiveness and safety of ruxolitinib for the treatment of refractory systemic idiopathic juvenile arthritis like associated with interstitial lung disease : a case report
Brigitte Bader-Meunier et al.
ANNALS OF THE RHEUMATIC DISEASES (2022)
Developmental Adaptive Immune Defects Associated with STAT5B Deficiency in Three Young Siblings
Corinne L. Foley et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2021)
STAT3 and its targeting inhibitors in osteosarcoma
Yun Liu et al.
CELL PROLIFERATION (2021)
Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis
Thi Hang Giang Phan et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2021)
JAK-STAT Pathway Inhibition and their Implications in COVID-19 Therapy
Sairaj Satarker et al.
POSTGRADUATE MEDICINE (2021)
The potential involvement of JAK-STAT signaling pathway in the COVID-19 infection assisted by ACE2
Jing Luo et al.
GENE (2021)
Persistent Post-COVID-19 Interstitial Lung Disease An Observational Study of Corticosteroid Treatment
Katherine Jane Myall et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2021)
Computationally predicted SARS-COV-2 encoded microRNAs target NFKB, JAK/STAT and TGFB signaling pathways
Merve Nur Aydemir et al.
GENE REPORTS (2021)
Discharge may not be the end of treatment: Pay attention to pulmonary fibrosis caused by severe COVID-19
Chi Zhang et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
Increased Pulmonary GM-CSF Causes Alveolar Macrophage Accumulation Mechanistic Implications for Desquamative Interstitial Pneumonitis
Takuji Suzuki et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2020)
Baricitinib experience on STING-associated vasculopathy with onset in infancy: A representative case from Turkey
Sibel Balci et al.
CLINICAL IMMUNOLOGY (2020)
Distinct molecular response patterns of activating STAT3 mutations associate with penetrance of lymphoproliferation and autoimmunity
Sabine Jaegle et al.
CLINICAL IMMUNOLOGY (2020)
Defining genetic risk factors for scleroderma-associated interstitial lung disease IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease
Carmel J. W. Stock et al.
CLINICAL RHEUMATOLOGY (2020)
Successful Treatment of Interstitial Lung Disease in STAT3 Gain-of-Function Using JAK Inhibitors
Manuel Silva-Carmona et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
JAK Inhibitors: Prospects in Connective Tissue Diseases
Hanxiao You et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2020)
Ionizing radiation modulates vascular endothelial growth factor expression through STAT3 signaling pathway in rat neonatal primary astrocyte cultures
Guijuan Zhou et al.
BRAIN AND BEHAVIOR (2020)
JAK Inhibition as a New Treatment Strategy for Patients with COVID-19
Farhad Seif et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2020)
Alveolar Epithelial Type II Cells as Drivers of Lung Fibrosis in Idiopathic Pulmonary Fibrosis
Tanyalak Parimon et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial
Yang Cao et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact
Fabrizio Cantini et al.
JOURNAL OF INFECTION (2020)
Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy
Peter M. George et al.
LANCET RESPIRATORY MEDICINE (2020)
Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution
Uddalak Bharadwaj et al.
PHARMACOLOGICAL REVIEWS (2020)
The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease
Dennis McGonagle et al.
AUTOIMMUNITY REVIEWS (2020)
Combined anti-fibrotic and anti-inflammatory properties of JAK-inhibitors on macrophages in vitro and in vivo: Perspectives for scleroderma-associated interstitial lung disease
Alain Lescoat et al.
BIOCHEMICAL PHARMACOLOGY (2020)
The cytokine storm of COVID-19: a spotlight on prevention and protection
Lucie Pearce et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2020)
Fibroblast-specific IL11 signaling drives chronic inflammation in murine fibrotic lung disease
Benjamin Ng et al.
FASEB JOURNAL (2020)
COVID-19: The Potential Treatment of Pulmonary Fibrosis Associated with SARS-CoV-2 Infection
Kacper Lechowicz et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Exhaled Biomarkers in Idiopathic Pulmonary Fibrosis-A Six-Month Follow-up Study in Patients Treated with Pirfenidone
Kaja Jaskiewicz et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Interleukin-6 Blocking vs. JAK-STAT Inhibition for Prevention of Lung Injury in Patients with COVID-19
Joseph Meletiadis et al.
INFECTIOUS DISEASES AND THERAPY (2020)
A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression
Samuel B. Polak et al.
MODERN PATHOLOGY (2020)
Effect of Total Flavonoids of Oxytropis falcata Bunge on the Expression of p-JAK1-and p-STAT1-Related Proteins in Idiopathic Pulmonary Fibrosis
Yan-jun Wang et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2020)
Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19
Wei Luo et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2020)
Efficacy of baricitinib in treating rheumatoid arthritis: Modulatory effects on fibrotic and inflammatory biomarkers in a real-life setting
Miriana d'Alessandro et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Baricitinib, a drug with potential effect to prevent SARS-COV-2 from entering target cells and control cytokine storm induced by COVID-19
Xiuhong Zhang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Clinical, Serological, and Histopathological Similarities Between Severe COVID-19 and Acute Exacerbation of Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD)
Daniel Gagiannis et al.
FRONTIERS IN IMMUNOLOGY (2020)
Interleukin-11 signaling underlies fibrosis, parenchymal dysfunction, and chronic inflammation of the airway
Benjamin Ng et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
Iacta Alea Est: The Inexorable Advance of Tofacitinib in the Treatment of Dermatomyositis-Associated Rapidly Progressive Interstitial Lung Disease. A Case Report
Walter Conca et al.
FRONTIERS IN PHARMACOLOGY (2020)
Baricitinib restrains the immune dysregulation in patients with severe COVID-19
Vincenzo Bronte et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
The JAK/STAT pathway is activated in systemic sclerosis and is effectively targeted by tofacitinib
Wenxia Wang et al.
JOURNAL OF SCLERODERMA AND RELATED DISORDERS (2020)
Pulmonary Fibrosis in COVID-19 Survivors: Predictive Factors and Risk Reduction Strategies
Ademola S. Ojo et al.
PULMONARY MEDICINE (2020)
Progression of fibrosing interstitial lung disease
Alyson W. Wong et al.
RESPIRATORY RESEARCH (2020)
JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis
George E. Fragoulis et al.
RHEUMATOLOGY (2019)
STAT3 gain of function: a new aetiology of severe rheumatic disease
Lisa Giovannini-Chami et al.
RHEUMATOLOGY (2019)
Elevation of IL-6 and IL-33 Levels in Serum Associated with Lung Fibrosis and Skeletal Muscle Wasting in a Bleomycin-Induced Lung Injury Mouse Model
Jiunn-Min Shieh et al.
MEDIATORS OF INFLAMMATION (2019)
Clinical Aspects of STAT3 Gain-of-Function Germline Mutations: A Systematic Review
Alexandre Fabre et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2019)
FGFR2 Promotes Expression of PD-L1 in Colorectal Cancer via the JAK/STAT3 Signaling Pathway
Piao Li et al.
JOURNAL OF IMMUNOLOGY (2019)
CELLULAR SENESCENCE: AGING, CANCER, AND INJURY
Arianna Calcinotto et al.
PHYSIOLOGICAL REVIEWS (2019)
Therapeutic Targeting of Fibrotic Epithelial-Mesenchymal Transition-An Outstanding Challenge
Attila Fintha et al.
FRONTIERS IN PHARMACOLOGY (2019)
Comparative phenotypic profiling of the JAK2 inhibitors ruxolitinib, fedratinib, momelotinib, and pacritinib reveals distinct mechanistic signatures
Jack W. Singer et al.
PLOS ONE (2019)
Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosis
Benjamin Ng et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
STAT3 Regulates the Onset of Oxidant-induced Senescence in Lung Fibroblasts
David W. Waters et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2019)
Mechanisms Underlying the Anti-inflammatory and Immunosuppressive Activity of Ruxolitinib
Elena Maria Elli et al.
FRONTIERS IN ONCOLOGY (2019)
Endotype-phenotyping may predict a treatment response in progressive fibrosing interstitial lung disease
Anna-Maria Hoffmann-Vold et al.
EBIOMEDICINE (2019)
JAK-STAT Signaling: A Double-Edged Sword of Immune Regulation and Cancer Progression
Katie L. Owen et al.
CANCERS (2019)
The Role of the Multidisciplinary Evaluation of Interstitial Lung Diseases: Systematic Literature Review of the Current Evidence and Future Perspectives
Federica Furini et al.
FRONTIERS IN MEDICINE (2019)
Tofacitinib facilitates the expansion of myeloid-derived suppressor cells and ameliorates interstitial lung disease in SKG mice
Sho Sendo et al.
ARTHRITIS RESEARCH & THERAPY (2019)
Transforming growth factor 1 promotes migration and invasion in HepG2 cells: Epithelial-to-mesenchymal transition via JAK/STAT3 signaling
Xiao-Long Lin et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2018)
Fibroblast senescence in the pathology of idiopathic pulmonary fibrosis
David W. Waters et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2018)
STAT3 Gain of Function: A New Kid on the Block in Interstitial Lung Diseases
Alexandre Fabre et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Role of the JAK/STAT signaling pathway in regulation of innate immunity in neuroinflammatory diseases
Zhaoqi Yan et al.
CLINICAL IMMUNOLOGY (2018)
Partial growth hormone insensitivity and dysregulatory immune disease associated with de novo germline activating STAT3 mutations
Mariana Gutierrez et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2018)
Idiopathic Pulmonary Fibrosis
David J. Lederer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Tofacitinib for refractory interstitial lung diseases in anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis
Kazuhiro Kurasawa et al.
RHEUMATOLOGY (2018)
JAK2 mediates lung fibrosis, pulmonary vascular remodelling and hypertension in idiopathic pulmonary fibrosis: an experimental study
Javier Milara et al.
THORAX (2018)
The role of the JAK/STAT signal pathway in rheumatoid arthritis
Charles J. Malemud
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2018)
Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations
Lisa R. Forbes et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Investigation of key autophagy-and mitophagy-related proteins and gene expression in BALF cells from patients with IPF and RA-ILD
Eirini Vasarmidi et al.
MOLECULAR MEDICINE REPORTS (2018)
The JAK2 pathway is activated in idiopathic pulmonary fibrosis
Javier Milara et al.
RESPIRATORY RESEARCH (2018)
STAT mutations as program switchers: turning primary immunodeficiencies into autoimmune diseases
Tiziana Lorenzini et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2017)
Bioinformatics analysis of gene expression profile data to screen key genes involved in pulmonary sarcoidosis
Hongyan Li et al.
GENE (2017)
Jak Stat signaling and cancer: Opportunities, benefits and side effects of targeted inhibition
Bernd Groner et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2017)
Both MAPK and STAT3 signal transduction pathways are necessary for IL-6-dependent hepatic stellate cells activation
Polina Kagan et al.
PLOS ONE (2017)
IL-13 and idiopathic pulmonary fibrosis: Possible links and new therapeutic strategies
Giovanni Passalacqua et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2017)
Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis
Debomita Chakraborty et al.
NATURE COMMUNICATIONS (2017)
Cellular senescence mediates fibrotic pulmonary disease
Marissa J. Schafer et al.
NATURE COMMUNICATIONS (2017)
IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway
Xiongyan Wu et al.
ONCOTARGET (2017)
Identification of Jak-STAT signaling involvement in sarcoidosis severity via a novel microRNA-regulated peripheral blood mononuclear cell gene signature
Tong Zhou et al.
SCIENTIFIC REPORTS (2017)
IPF lung fibroblasts have a senescent phenotype
Diana Alvarez et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2017)
IL-6 promotes epithelial-to-mesenchymal transition of human peritoneal mesothelial cells possibly through the JAK2/STAT3 signaling pathway
Jing Xiao et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2017)
JAK1-dependent transphosphorylation of JAK2 limits the antifibrotic effects of selective JAK2 inhibitors on long-term treatment
Yun Zhang et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
JAK-STAT signalling and the atrial fibrillation promoting fibrotic substrate
Yu Chen et al.
CARDIOVASCULAR RESEARCH (2017)
JAK-STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects
Shubhasree Banerjee et al.
DRUGS (2017)
Update in diagnosis and management of interstitial lung disease
Theresia A. Mikolasch et al.
CLINICAL MEDICINE (2017)
Epithelial-mesenchymal transition: An emerging target in tissue fibrosis
Meirong Li et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2016)
Influences of innate immunity, autophagy, and fibroblast activation in the pathogenesis of lung fibrosis
David N. O'Dwyer et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2016)
PDGF-BB induces PRMT1 expression through ERK1/2 dependent STAT1 activation and regulates remodeling in primary human lung fibroblasts
Qingzhu Sun et al.
CELLULAR SIGNALLING (2016)
STAT-3 contributes to pulmonary fibrosis through epithelial injury and fibroblast-myofibroblast differentiation
Mesias Pedroza et al.
FASEB JOURNAL (2016)
STAT5B deficiency: Impacts on human growth and immunity
Vivian Hwa
GROWTH HORMONE & IGF RESEARCH (2016)
Tofacitinib or adalimumab versus placebo: patient-reported outcomes from a phase 3 study of active rheumatoid arthritis
Vibeke Strand et al.
RHEUMATOLOGY (2016)
The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention
John J. O'Shea et al.
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
The Fibroblast Growth Factor signaling pathway
David M. Ornitz et al.
WILEY INTERDISCIPLINARY REVIEWS-DEVELOPMENTAL BIOLOGY (2015)
Inhibition of casein kinase II reduces TGFβ induced fibroblast activation and ameliorates experimental fibrosis
Yun Zhang et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations
Joshua D. Milner et al.
BLOOD (2015)
JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells
Reng-Yun Liu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Blockade of IL-6 Trans Signaling Attenuates Pulmonary Fibrosis
Thanh-Thuy T. Le et al.
JOURNAL OF IMMUNOLOGY (2014)
Discovery and Development of Janus Kinase (JAK) Inhibitors for Inflammatory Diseases
James D. Clark et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
PERK-Dependent Activation of JAK1 and STAT3 Contributes to Endoplasmic Reticulum Stress-Induced Inflammation
Gordon P. Meares et al.
MOLECULAR AND CELLULAR BIOLOGY (2014)
Respiratory bronchiolitis-interstitial lung disease
Alicja Sieminska et al.
ORPHANET JOURNAL OF RARE DISEASES (2014)
IPF Fibroblasts Are Desensitized to Type I Collagen Matrix-Induced Cell Death by Suppressing Low Autophagy via Aberrant Akt/mTOR Kinases
Richard Seonghun Nho et al.
PLOS ONE (2014)
Pathogenesis pathways of idiopathic pulmonary fibrosis in bleomycin-induced lung injury model in mice
Keyun Shi et al.
RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY (2014)
Interstitial lung disease
Katerina M. Antoniou et al.
EUROPEAN RESPIRATORY REVIEW (2014)
EFFECTS OF MATRINE ON JAK-STAT SIGNALING TRANSDUCTION PATHWAYS IN BLEOMYCIN-INDUCED PULMONARY FIBROSIS
Xiuqin Ma et al.
AFRICAN JOURNAL OF TRADITIONAL COMPLEMENTARY AND ALTERNATIVE MEDICINES (2013)
Insufficient autophagy in idiopathic pulmonary fibrosis
Jun Araya et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2013)
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
William D. Travis et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Tyrosine kinase signaling in fibrotic disorders Translation of basic research to human disease
Christian Beyer et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
Oxidative stress and pulmonary fibrosis
Paul Cheresh et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
Roles of STAT3 in Protein Secretion Pathways during the Acute-Phase Response
Ayele-Nati N. Ahyi et al.
INFECTION AND IMMUNITY (2013)
Microarray profiling reveals suppressed interferon stimulated gene program in fibroblasts from scleroderma-associated interstitial lung disease
Gisela E. Lindahl et al.
RESPIRATORY RESEARCH (2013)
Sorafenib ameliorates bleomycin-induced pulmonary fibrosis: potential roles in the inhibition of epithelial-mesenchymal transition and fibroblast activation
Y-L Chen et al.
CELL DEATH & DISEASE (2013)
Increased Expression of Epidermal Growth Factor Receptor (EGF-R) in Patients with Different Forms of Lung Fibrosis
Argyris Tzouvelekis et al.
BIOMED RESEARCH INTERNATIONAL (2013)
STAT3-Mediated Signaling Dysregulates Lung Fibroblast-Myofibroblast Activation and Differentiation in UIP/IPF
Dmitri V. Pechkovsky et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Genetic partitioning of interleukin-6 signalling in mice dissociates Stat3 from Smad3-mediated lung fibrosis
Robert J. J. O'Donoghue et al.
EMBO MOLECULAR MEDICINE (2012)
Dynamics and non-canonical aspects of JAK/STAT signalling
Anne Mohr et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2012)
Targeting the TGFβ signalling pathway in disease
Rosemary J. Akhurst et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Autophagy in Idiopathic Pulmonary Fibrosis
Avignat S. Patel et al.
PLOS ONE (2012)
STAT5b Deficiency: An Unsuspected Cause of Growth Failure, Immunodeficiency, and Severe Pulmonary Disease
Kari Nadeau et al.
JOURNAL OF PEDIATRICS (2011)
Endoplasmic reticulum stress enhances fibrotic remodeling in the lungs
William E. Lawson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Acute Interstitial Pneumonia (Hamman-Rich Syndrome) as a Cause of Idiopathic Acute Respiratory Distress Syndrome
Jackrapong Bruminhent et al.
CASE REPORTS IN MEDICINE (2011)
The Safety and Efficacy of a JAK Inhibitor in Patients With Active Rheumatoid Arthritis Results of a Double-Blind, Placebo-Controlled Phase IIa Trial of Three Dosage Levels of CP-690,550 Versus Placebo
Joel M. Kremer et al.
ARTHRITIS AND RHEUMATISM (2009)
Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial-mesenchymal transition in ovarian carcinomas
M. Colomiere et al.
BRITISH JOURNAL OF CANCER (2009)
Lung alveolar epithelium and interstitial lung disease
Harriet Corvol et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
Nonspecific Interstitial Pneumonia: Radiologic, Clinical, and Pathologic Considerations
Seth J. Kligerman et al.
RADIOGRAPHICS (2009)
Tocilizumab: The first interleukin-6-receptor inhibitor
Anthony Sebba
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2008)
Endoplasmic reticulum stress in alveolar epithelial cells is prominent in IPF: association with altered surfactant protein processing and herpesvirus infection
William E. Lawson et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2008)
Epithelial endoplasmic reticulum stress and apoptosis in sporadic idiopathic pulmonary fibrosis
Martina Korfei et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Mechanisms of Oncostatin M-Induced Pulmonary Inflammation and Fibrosis
Afsaneh Mozaffarian et al.
JOURNAL OF IMMUNOLOGY (2008)
The role of apoptosis in pulmonary fibrosis
B. D. Uhal
EUROPEAN RESPIRATORY REVIEW (2008)
What every radiologist should know about idiopathic interstitial pneumonias
Christina Mueller-Mang et al.
RADIOGRAPHICS (2007)
1-year pulmonary function and health status in survivors of severe acute respiratory syndrome
KC Ong et al.
CHEST (2005)
Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors
DS Hui et al.
THORAX (2005)
Regulation of found in inflammatory zone 1 expression in bleomycin-induced lung fibrosis: Role of IL-4/IL-13 and mediation via STAT-6
TJ Liu et al.
JOURNAL OF IMMUNOLOGY (2004)
Angiogenic cytokines in patients with idiopathic interstitial pneumonia
NR Simler et al.
THORAX (2004)
Cryptogenic organizing pneumonia
JF Cordier
CLINICS IN CHEST MEDICINE (2004)
Human pulmonary fibroblasts exhibit altered interleukin-4 and interleukin-13 receptor subunit expression in idiopathic interstitial pneumonia
C Jakubzick et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Therapeutic targeting of IL-4- and IL-13-responsive cells in pulmonary fibrosis
C Jakubzick et al.
IMMUNOLOGIC RESEARCH (2004)
Inverse effects of interleukin-6 on apoptosis of fibroblasts from pulmonary fibrosis and normal lungs
YP Moodley et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2003)
Thin-section CT in patients with severe acute respiratory syndrome following hospital discharge: Preliminary experience
GE Antonio et al.
RADIOLOGY (2003)
Fibroblasts isolated from normal lungs and those with idiopathic pulmonary fibrosis differ in interleukin-6/gp130-mediated cell signaling and proliferation
YP Moodley et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis
GL Niu et al.
ONCOGENE (2002)
Evidence of type II pneumocyte apoptosis in the pathogenesis of idiopathic pulmonary fibrosis (IFP)/usual interstitial pneumonia (UIP)
JV Barbas-Filho et al.
JOURNAL OF CLINICAL PATHOLOGY (2001)
Increased levels of interleukin-6 are associated with lymphocytosis in bronchoalveolar lavage fluids of idiopathic nonspecific interstitial pneumonia
CS Park et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Share Paper
